Trexquant Investment’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Trexquant Investment’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,006	Closed	-$106K	–	1679
2021 Q1	$106K	Buy	+25,006	New	+$138K	0.01%	1053
2019 Q3	–	Sell	-22,482	Closed	-$208K	–	1246
2019 Q2	$208K	Buy	22,482 +11,074	+97%	+$83.5K	0.02%	681
2019 Q1	$73K	Sell	11,408 -1,921	-14%	-$12.5K	0.01%	942
2018 Q4	$126K	Buy	+13,329	New	+$201K	0.01%	974
2018 Q3	–	Sell	-10,413	Closed	-$304K	–	1352
2018 Q2	$304K	Sell	10,413 -16,269	-61%	-$502K	0.02%	674
2018 Q1	$795K	Buy	+26,682	New	+$860K	0.06%	483
2017 Q4	–	Sell	-6,230	Closed	-$217K	–	1402
2017 Q3	$217K	Buy	+6,230	New	+$200K	0.05%	600
2015 Q3	–	Sell	-19,400	Closed	-$475K	–	1502
2015 Q2	$475K	Buy	+19,400	New	+$400K	0.05%	641

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trexquant Investment's LJPC Position: Q2 2021 in Review

Trexquant Investment sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 25,006 shares — an estimated $106K sold.

Trexquant Investment first reported a position in LJPC in Q2 2015 and held it in 8 quarters. The position peaked at $795K in Q1 2018. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

Trexquant Investment reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
Trexquant Investment sold 25,006 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $106K.
Trexquant Investment first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 8 quarters.
Trexquant Investment's La Jolla Pharmaceutical Company position peaked at $795K in Q1 2018.
62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Trexquant Investment's 13F filing for Q2 2021, filed 12 Aug 2021.